Results 101 to 110 of about 109,240 (286)

Acute hemorrhagic edema of young children: a concise narrative review [PDF]

, 2018
Acute hemorrhagic edema of young children is an uncommon but likely underestimated cutaneous leukocytoclastic vasculitis. The condition typically affects infants 6-24months of age with a history of recent respiratory illness with or without course of ...
Bettinelli, Alberto, Bianchetti, Mario, Fiore, Elisabetta, Garzoni, Luca, Rizzi, Mattia, Simonetti, Giacomo   +5 more
core  

Increased plasma concentration of vascular endothelial growth factor in patients with atopic dermatitis and its relation to disease severity and platelet activation [PDF]

, 2012
BACKGROUND: Overproduction of vascular endothelial growth factor (VEGF) in atopic dermatitis (AD) lesions has previously been observed. It is also known that platelet is an important source of VEGF and platelet factor 4 (PF-4), a potential marker of AD ...
A. Kasperska-Zajac, E. Koczy-Baron, J. Jochem   +2 more
core   +1 more source

Under-reported finding in acral erythema multiforme

Indian Journal of Dermatology, 2015
Erythema multiforme is an acute muco-cutaneous hypersensitivity reaction with a variety of etiologies. It is characterized by a skin eruption, with or without oral or other mucous membrane lesions. General characteristics and treatmet have been described 
Adriana G Pena Romero, Judith Dominguez Cherit, Amanda C Guzman Abrego   +2 more
doaj   +1 more source

Erythema multiforme‐like allergic contact dermatitis from bay leaves in a home‐made natural remedy [PDF]

, 2023
Alicia Martínez‐Fernández, Consuelo Sánchez‐Herreros, Raquel Cabana‐Navia, José‐María Camino‐Salvador, Sara Palomo‐Cousido, Paloma Arribas‐Granados, María E. Gatica‐Ortega, María A. Pastor‐Nieto   +7 more
openalex   +1 more source

Erythema multiforme: Differences between HSV‐1 and HSV‐2 and management of the disease—A case report and mini review

Dermatologic Therapy, 2019
Erythema multiforme (EM) is an immune‐mediated reaction characterized by target lesions and with possible mucosal involvement. Its most frequent cause is HSV, with HSV‐1 more common than −2. It is usually self‐limited but it can show recurrences.
F. Magri, C. Chello, G. Pranteda, G. Pranteda   +3 more
semanticscholar   +1 more source

Angina Bullosa Hemorrhagica: A Rare Case Involving the Ventral Tongue

Clinical Case Reports, Volume 14, Issue 1, January 2026.
ABSTRACT Angina bullosa hemorrhagica (ABH) is a rare benign condition characterized by the sudden onset of hemorrhagic blisters in the oral mucosa, often triggered by minor trauma. We report a case of ABH in a 55‐year‐old woman with a history of asthma managed with inhaled corticosteroids who presented with a painful blister on the ventral tongue, an ...
Fatemeh Khajehzadeh
wiley   +1 more source

Mucocutaneous Manifestation of Systemic Lupus Erythematosus Patients at Rheumatology Outpatient Clinic in Dr. Hasan Sadikin General Hospital [PDF]

, 2017
Background: Systemic Lupus Erythematosus (SLE) is an autoimmune systemic disease which symptoms induced by Ultraviolet rays exposure. It commonly affects women and causes wide range of symptoms. One of the organs affected is mucocutaneous. Our study aims
Dharmadji, H. P. (Hartati), Hamijoyo, L. (Laniyati), Sungkar, E. (Ellyana), Veimern, C. A. (Chin)   +3 more
core  

Erythema multiforme as the result of taking carbamazepine

Dental Journal, 2010
Background: Erythema multiforme is an acute mucocutaneus disease which is caused by the hypersensitivity reaction. It is characterized by target lesions on the skin or ulcerative oral lesion. Etiology of the disease is unknown, it is currently considered
Maharani Laillyza Apriasari, M. Jusri
doaj   +1 more source

TALOs, Fill the Gap: Tafasitamab and Lenalidomide in Diffuse Large B‐Cell Lymphoma in the Real‐Life Patient Journey

Hematological Oncology, Volume 44, Issue 1, January 2026.
ABSTRACT The combination of tafasitamab and lenalidomide (tafa‐lena) has demonstrated efficacy in relapsed/refractory diffuse large B‐cell lymphoma (R/R DLBCL), as evidenced by the L‐MIND study. To investigate the therapeutic potential and safety profile of tafa‐lena in real‐life, we conducted a national multicentric retrospective study.
Lisa Argnani, Cinzia Pellegrini, Ombretta Annibali, Piera Angelillo, Enrico Amaducci, Filippo Ballerini, Flaminia Bellisario, Andrea Bernardelli, Riccardo Bruna, Catello Califano, Giusy Cetani, Giulia Daghia, Enrico Derenzini, Antonio Frolli, Francesco Gaudio, Valerio Guarente, Ausilia Gorgone, Liardo Eliana Valentina, Elisa Lucchini, Dario Marino, Luca Nassi, Paolo Nicoli, Mattia Novo, Francesca Palombi, Caterina Patti, Vincenzo Pavone, Marcello Riva, Filomena Russo, Greta Scapinello, Alessandro Severino, Monica Tani, Daniele Vallisa, Beatrice Casadei, Alessandro Broccoli, Pier Luigi Zinzani   +34 more
wiley   +1 more source

Exclusions affect representativeness of Alzheimer's disease trial participants

Alzheimer's &Dementia: Translational Research &Clinical Interventions, Volume 12, Issue 1, January/March 2026.
Abstract BACKGROUND This study assessed how medical exclusion criteria of a prevention Alzheimer's disease trial impact potential eligibility and sample characteristics. METHODS Medical exclusion criteria from the Anti‐Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) trial were applied to N = 3695 participants from the population‐based Health
Miriam T. Ashford, Rachana Tank, Mohammed U. Kabeto, Rachel L. Nosheny, Michael W. Weiner, David R. Weir, Kenneth M. Langa   +6 more
wiley   +1 more source